UASt regulatory sequences drive expression of an inverted repeat.
Expression of EgfrKK100051 under the control of Scer\GAL4elav.PU leads to more rapid ethanol sedation compared to controls.
Reducing Egfr levels by EgfrKK100051-mediated knockdown in the posterior wing compartment (under the control of Scer\GAL4en-e16E), leads to the loss of the lateral vein L4 and the apical crossvein, along with some growth defects.
Knockdown of Egfr in wing margin cells, through the expression of EgfrKK100051 under the control of Scer\GAL4wg-IS650 and Scer\GAL80ts.αTub84B results in extra apoptosis even at 30 hours after pupal formation. As a result of this apoptosis, some inter-hair cells are lost.
EgfrKK100051/Scer\GAL4elav.PU is a suppressor | partially of chemical resistant | adult stage phenotype of DopEcRc02142
EgfrKK100051/Scer\GAL4DopEcR-GAL4 is a suppressor | partially of chemical resistant | adult stage phenotype of DopEcRGAL4
EgfrKK100051, Scer\GAL4NP5130 is a suppressor of hyperplasia phenotype of Scer\GAL4NP5130, Src42ACA.UAS
EgfrKK100051, Scer\GAL4en-e16E has wing vein L4 phenotype, enhanceable by stepRNAi.UAS, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has crossvein phenotype, enhanceable by stepRNAi.UAS, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has wing phenotype, enhanceable by stepRNAi.UAS, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has wing vein phenotype, enhanceable by stepRNAi.UAS, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has wing vein L4 phenotype, suppressible by stepUAS.FL, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has crossvein phenotype, suppressible by stepUAS.FL, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has wing phenotype, suppressible by stepUAS.FL, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4en-e16E has wing vein phenotype, suppressible by stepUAS.FL, Scer\GAL4en-e16E
EgfrKK100051, Scer\GAL4NP5130 is a suppressor of intestinal stem cell of posterior adult midgut epithelium phenotype of Scer\GAL4NP5130, Src42ACA.UAS
The increased resistance to ethanol-induced sedation characteristic for both DopEcRc02142 and DopEcRGAL4 homozygous adults is significantly suppressed by expression of EgfrKK100051 under the control of the Scer\GAL4elav.PU driver in the DopEcRc02142 background or the intrinsic Scer\GAL4DopEcR-GAL4 driver in the DopEcRGAL4 mutants.
Reducing Egfr levels by EgfrKK100051-mediated knockdown in the posterior wing compartment (under the control of Scer\GAL4en-e16E), in a stepdsRNA.Scer\UAS background generates a more severe Egfr phenotype. The lateral vein L4 is entirely lost, both cross veins are not differentiated and the distal end of the lateral vein L5 is missing.
Expression of stepScer\UAS.FL suppresses the wing vein defects caused by expression of EgfrKK100051 in the posterior compartment of the wing, under the control of Scer\GAL4en-e16E.